AdaptHealth Corp.
Income Statement
| Line Item | Jul 2026 | Jun 2026 | May 2026 | Mar 2026 | Feb 2026 | Dec 2025 | Oct 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $740.3M | — | $819.8M | — | — | — | $820.3M |
| Cost of Revenue | — | $636.1M | — | $708.3M | — | — | — | $658.4M |
| Gross Profit | — | $104.2M | — | $111.5M | — | — | — | $161.9M |
| Gross Margin | — | 14.1% | — | 13.6% | — | — | — | 19.7% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $96.1M | — | $95.9M | — | — | — | $90.1M |
| Operating Income | — | $-137.8M | — | $5.5M | — | — | — | $61.7M |
| Operating Margin | — | -18.6% | — | 0.7% | — | — | — | 7.5% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $-165.3M | — | $-20.1M | — | — | — | $36.4M |
| Income Tax Expense | — | $-21.2M | — | $-5.2M | — | — | — | $10.6M |
| Net Income | — | $-133.9M | — | $-16.0M | — | — | — | $24.5M |
| Net Margin | — | -18.1% | — | -2.0% | — | — | — | 3.0% |
| EPS (Basic) | — | $-0.99 | — | $-0.12 | — | — | — | $0.17 |
| EPS (Diluted) | — | $-0.99 | — | $-0.12 | — | — | — | $0.16 |
| Shares Outstanding (Basic) | 136.3M | 136.1M | 136.1M | 135.8M | 135.9M | 135.5M | 135.4M | 135.3M |
| Shares Outstanding (Diluted) | 136.3M | 136.1M | 136.1M | 135.8M | 135.9M | 135.5M | 135.4M | 137.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |